PetMed Express (NASDAQ:PETS – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.30, Zacks reports. PetMed Express had a negative return on equity of 7.09% and a negative net margin of 2.85%. The firm had revenue of $67.95 million during the quarter, compared to analyst estimates of $77.52 million.
PetMed Express Stock Down 14.4 %
NASDAQ:PETS traded down $0.53 during trading hours on Wednesday, hitting $3.16. 712,366 shares of the company’s stock traded hands, compared to its average volume of 386,915. The firm has a market cap of $65.12 million, a P/E ratio of -8.10 and a beta of 0.73. PetMed Express has a 52 week low of $3.14 and a 52 week high of $13.23. The business’s fifty day simple moving average is $4.01 and its two-hundred day simple moving average is $4.59.
Analyst Ratings Changes
PETS has been the subject of a number of analyst reports. Lake Street Capital reaffirmed a “hold” rating and issued a $3.50 price target (down from $7.00) on shares of PetMed Express in a report on Wednesday. Morgan Stanley cut their price target on PetMed Express from $6.50 to $3.50 and set an “underweight” rating for the company in a report on Wednesday, June 12th.
PetMed Express Company Profile
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Recommended Stories
- Five stocks we like better than PetMed Express
- The How and Why of Investing in Gold Stocks
- What Are Bonds? A High-Level Overview
- Dividend Capture Strategy: What You Need to Know
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- Why is the Ex-Dividend Date Significant to Investors?
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.
